selectively targeting Nrf2-activated pancreatic cancer by inhibiting asparagine synthesis pathway; induction of apoptosis in Nrf2-activated pancreatic cancer cells independent of ROS. Here, NFE2L2 is linked to familial pancreatic carcinoma.